Published 2010 | Version v1.0.0
Journal Article Open

Topiramate and Cognitive Function in Migraine

Abstract

Researchers at the Johnson & Johnson Pharmaceutical Research & Development, New Jersey and Belgium, and University of California, Los Angeles, CA used the Cambridge Neuropsychological Test Automated Battery (CANTAB) and cognitive adverse events to evaluate neurocognitive effects of topiramate 100 mg/day vs placebo in 70 migraine patients aged 12 through 17 years.

Files

PNB-24-23-a.pdf

Files (1.2 MB)

Name Size Download all
md5:d53419be97e35ea6097b318928f797b0
1.2 MB Preview Download

Additional details

Identifiers

Other
PNB-24-23-a

Dates

Created
2010
When the item was originally created.